Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.09.2023 | Case report

Abemaciclib

Hepatotoxicity, emesis and diarrhoea: 5 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Jacobs F, et al. Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib. Journal of Clinical Medicine 12: No. 5, Mar 2023. Available from: URL: http://doi.org/10.3390/jcm12051775 Jacobs F, et al. Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib. Journal of Clinical Medicine 12: No. 5, Mar 2023. Available from: URL: http://​doi.​org/​10.​3390/​jcm12051775
Metadaten
Titel
Abemaciclib
Hepatotoxicity, emesis and diarrhoea: 5 case reports
Publikationsdatum
01.09.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45395-5

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Immune-globulin

Case report

Multiple drugs